Gregory W. Carter

Transfer learning‐trained convolutional neural networks identify novel MRI biomarkers of Alzheimer's disease progression

Christoph Preuss, G. Carter, V. Philip, 2021, Alzheimer's & dementia.

Discovery of FERM domain protein–protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer’s disease

T. Willson, A. Wingo, N. Seyfried, 2023, The Journal of biological chemistry.

In vivo validation of late-onset Alzheimer's disease genetic risk factors.

Christoph Preuss, A. Oblak, A. Uyar, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Genetic diversity promotes resilience in a mouse model of Alzheimer's disease

C. Kaczorowski, A. Uyar, S. Kawauchi, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Metabolomics profiling reveals distinct, sex‐specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease

M. Sasner, Dylan T. Garceau, Harriet Williams, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Early molecular events of autosomal‐dominant Alzheimer's disease in marmosets with PSEN1 mutations

Anna K. Greenwood, Catrina A. Spruce, S. J. Sukoff Rizzo, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshop

C. Kaczorowski, P. Territo, K. Onos, 2024, Alzheimer's & dementia.

Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains

Benjamin A. Logsdon, Anna K. Greenwood, L. Mangravite, 2022, medRxiv.

Gene replacement‐Alzheimer's disease (GR‐AD): Modeling the genetics of human dementias in mice

M. Koob, K. Benzow, Adrian L. Oblak, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.